本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

奥麦罗制药

9.08
+1.2115.37%
盘后9.120.0400+0.44%19:55 EST
成交量:384.95万
成交额:3,331.40万
市值:6.44亿
市盈率:-4.31
高:9.10
开:7.90
低:7.72
收:7.87
52周最高:13.60
52周最低:2.95
股本:7,090.05万
流通股本:6,455.08万
量比:1.86
换手率:5.96%
股息:- -
股息率:- -
每股收益(TTM):-2.1063
每股收益(LYR):-2.6958
净资产收益率:-576.33%
总资产收益率:-31.06%
市净率:-2.82
市盈率(LYR):-3.37

数据加载中...

2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/29

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/11/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/09

重要事件披露

8-K - Current report
2020/08/14

重要事件披露

8-K - Current report
2020/08/12

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/08/10

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/08/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/10

重要事件披露

8-K - Current report
2020/06/11

重要事件披露

8-K - Current report
2020/05/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/05/11

重要事件披露

8-K - Current report
2020/05/04

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/03/02

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/03/02

重要事件披露

Current report, items 2.02 and 9.01
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals